PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 172 filers reported holding PDL BIOPHARMA INC in Q2 2017. The put-call ratio across all filers is 0.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $39,000 | -91.3% | 14,200 | -89.3% | 0.00% | -85.7% |
| Q3 2017 | $449,000 | +816.3% | 132,477 | +562.4% | 0.01% | +600.0% |
| Q2 2017 | $49,000 | -96.9% | 20,000 | -95.8% | 0.00% | -96.0% |
| Q3 2016 | $1,590,000 | +69.1% | 474,610 | +78.7% | 0.02% | +257.1% |
| Q4 2015 | $940,000 | -72.2% | 265,544 | -44.9% | 0.01% | -85.1% |
| Q1 2015 | $3,387,000 | -14.6% | 481,528 | -6.4% | 0.05% | -7.8% |
| Q4 2014 | $3,967,000 | -27.7% | 514,605 | -29.9% | 0.05% | -29.2% |
| Q3 2014 | $5,487,000 | – | 734,391 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |